Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects
Open accessThe DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
Abstract
Intravenous iron is commonly used in conjunction with erythropoietic agents to treat anemia in patients with chronic kidney disease. Iron has been proposed to promote oxidative stress and endothelial dysfunction in vascular tissues. We studied the acute effects of intravenous iron sucrose on homocysteine-induced endothelial dysfunction in the brachial artery of normal human subjects. In all, 40 healthy subjects received intravenous iron sucrose 100 mg or placebo over 30 min immediately before ingestion of 100 mg/kg of oral methionine in a double-blind, randomized study. Flow- and nitroglycerin-mediated dilation in the brachial artery, serum markers of iron stores, and homocysteine and nitrotyrosine levels were measured before and after study drug administration. Intravenous iron significantly increased transferrin saturation and non-transferrin-bound iron (NTBI) when compared with placebo. Flow-mediated dilation significantly decreased from baseline 1 h after administration of iron sucrose when compared with placebo (from 6.66+/-0.47 to 1.93+/-0.35% after iron sucrose vs from 6.00+/-0.40 to 5.61+/-0.46% after placebo, P<0.001), but did not differ between groups at 4 h (1.10+/-0.39 vs 1.33+/-0.51%). Nitroglycerin-mediated vasodilation, and homocysteine and 3-nitrotyrosine levels did not differ after administration of iron sucrose and placebo. Intravenous administration of iron sucrose in the setting of transient hyperhomocysteinemia induced by methionine ingestion significantly increased transferrin saturation and plasma levels of NTBI and significantly attenuated flow-mediated dilation in the brachial artery when compared with placebo. This potential mechanistic link between intravenous iron and endothelial dysfunction warrants further study of cardiovascular effects of intravenous iron in anemic chronic kidney disease populations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the well-known adverse vascular effects of homocysteine (in inhibiting flow-mediated dilatation) are in fact iron-dependent [701-703]”
Citations
Cites
Corretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D., Charbonneau, F., Creager, M. A., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01746-6 · Cited by 4,604
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Nitric oxide, oxidants, and protein tyrosine nitration
Radi, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307446101 · Cited by 1,457
Kalantar-Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,148
IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK
Sullivan, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92463-6 · Cited by 969
The oxidant stress of hyperhomocyst(e)inemia.
Loscalzo, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118776 · Cited by 717
Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
Ubbink, J. B., Hayward Vermaak, W. J., & Bissbort, S. (1991) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(91)80407-4 · Cited by 678
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase
Upchurch, G. R., Welch, G. N., Fabian, A. J., Freedman, J. E., Johnson, J. L., Keaney, J. F., & Loscalzo, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17012 · Cited by 668
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“) It is of particular interest that the well-known adverse vascular effects of homocysteine (in inhibiting flow-mediated dilatation) are in fact irondependent [608-610], and that reducing homocysteine (e.”
BackgroundThe Role of Iron in Diabetes and Its Complications
Swaminathan, S., Fonseca, V. A., Alam, M. G., & Shah, S. V. (2007) · Diabetes Care · doi:10.2337/dc06-2625 · Cited by 423
A randomized trial of intravenous and oral iron in chronic kidney disease
Agarwal, R., Kusek, J. W., & Pappas, M. K. (2015) · Kidney International · doi:10.1038/ki.2015.163 · Cited by 200
Acute Injury with Intravenous Iron and Concerns Regarding Long-Term Safety
Bishu, K., & Agarwal, R. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01420406 · Cited by 98
“(31) evaluated in a double-blind, controlled experiment the effect of iron sucrose given in a recommended dose (100 mg) but at a slower rate (30 min rather than 5 min) to assess its effect on endothelial function as measured by flow-mediated dilation in 40 healthy volunteers.”
BackgroundGhafourian, K., Shapiro, J. S., Goodman, L., & Ardehali, H. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.08.009 · Cited by 105
Metadata
- Authors
- Zheng, H., Huang, X., Zhang, Q., & Katz, S. D.
- Affiliations
- Yale University (US)
- New York University (US)
- Corresponding author
- Katz, S.D.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 69
- Issue
- 4
- Pages
- 679-684
- ISSN
- 0085-2538 (ISSN-L)
- PMC
- PMC2988421
- OpenAlex
- W2067573387
- Cited by
- 44
- References
- 64
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3596 d)
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- Yale University
- National Center for Research Resources ((5 MO1 RR00645, M01RR000645)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- iron sucrose, endothelial dysfunction, homocysteine, hyperhomocysteinemia, flow-mediated dilation, non-transferrin-bound iron, transferrin saturation, nitrotyrosine, oxidative stress, brachial artery, intravenous iron, anemia of chronic kidney disease, cardiovascular risk
- MeSH terms
- Ferric Oxide, Saccharated, Adult, Brachial Artery, Cardiovascular Diseases, Chelating Agents, Double-Blind Method, Endothelium, Vascular, Female, Ferric Compounds, Ferritins, Glucaric Acid, Nitroglycerin, Homocysteine, Humans, Iron, Male, Methionine, Razoxane, Regional Blood Flow, Risk Factors, Transferrin, Tyrosine, Vasodilation, Oxidative Stress, Anemia, Iron-Deficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. https://app.cochat.ai/papers/10.1038/sj.ki.5000046
- The paper
- Zheng, H., Huang, X., Zhang, Q., & Katz, S. D. (2006). Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. Kidney International. https://doi.org/10.1038/sj.ki.5000046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.